Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin - Reply

被引:15
|
作者
Zeuzem, S [1 ]
机构
[1] Saarland Univ Hosp, D-66421 Homburg, Germany
关键词
D O I
10.1016/j.jhep.2004.11.012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:276 / 277
页数:2
相关论文
共 50 条
  • [1] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
  • [2] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    [J]. DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [3] Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection
    Pawlotsky, Jean-Michel
    Flisiak, Robert
    Sarin, Shiv K.
    Rasenack, Jens
    Piratvisuth, Teerha
    Chuang, Wan-Long
    Peng, Cheng-Yuan
    Foster, Graham R.
    Shah, Samir
    Wedemeyer, Heiner
    Hezode, Christophe
    Zhang, Wei
    Wong, Kelly A.
    Li, Bin
    Avila, Claudio
    Naoumov, Nikolai V.
    [J]. HEPATOLOGY, 2015, 62 (04) : 1013 - 1023
  • [4] TREATMENT EFFICACY OF PEGYLATED INTERFERON PLUS RIBAVIRIN IN PATIENTS INFECTED WITH GENOTYPE 6 HEPATITIS C VIRUS
    Shin, S. R.
    Park, S. H.
    Lee, M. S.
    Lee, J. W.
    Lee, J. S.
    Kim, Y. S.
    Choi, M. S.
    Kim, S. M.
    Jeong, S. -H.
    Shon, J. H.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S480 - S480
  • [5] Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
    Abbas, Zaigham
    Tayyab, Ghiasun Nabi
    Qureshi, Mustafa
    Memon, Mohammad Sadik
    Subhan, Amna
    Shakir, Tanzila
    Jafri, Wasim
    Hamid, Saeed
    [J]. HEPATITIS MONTHLY, 2013, 13 (12)
  • [6] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    [J]. CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [7] Efficacy of interferon plus ribavirin in the treatment of hepatitis C virus genotype 5
    Antaki, N.
    Hermes, A.
    Hadad, M.
    Ftayeh, M.
    Antaki, F.
    Abdo, N.
    Kebbewar, K.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2008, 15 (05) : 383 - 386
  • [8] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Kogure, Takayuki
    Ueno, Yoshiyuki
    Fukushima, Koji
    Nagasaki, Futoshi
    Kondo, Yasuteru
    Inoue, Jun
    Matsuda, Yasunori
    Kakazu, Eiji
    Yamamoto, Takeshi
    Onodera, Hiroyoshi
    Miyazaki, Yutaka
    Okamoto, Hiromasa
    Akahane, Takehiro
    Kobayashi, Tomoo
    Mano, Yutaka
    Iwasaki, Takao
    Ishii, Motoyasu
    Shimosegawa, Tooru
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (47) : 7225 - 7230
  • [9] Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan
    Takayuki Kogure
    Yoshiyuki Ueno
    Koji Fukushima
    Futoshi Nagasaki
    Yasuteru Kondo
    Jun Inoue
    Yasunori Matsuda
    Eiji Kakazu
    Takeshi Yamamoto
    Hiroyoshi Onodera
    Yutaka Miyazaki
    Hiromasa Okamoto
    Takehiro Akahane
    Tomoo Kobayashi
    Yutaka Mano
    Takao Iwasaki
    Motoyasu Ishii
    Tooru Shimosegawa
    [J]. World Journal of Gastroenterology, 2008, 14 (47) : 7225 - 7230
  • [10] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45